Saakshi Khattri Selected Research

fezakinumab

1/2019	Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
1/2018	Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saakshi Khattri Research Topics

Disease

10	Atopic Dermatitis (Atopic Eczema) 01/2019 - 06/2014
4	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2021 - 01/2017
2	Hyperplasia 01/2018 - 06/2014
2	Inflammation (Inflammations) 01/2017 - 06/2014
2	Autoimmune Diseases (Autoimmune Disease) 08/2015 - 07/2013
2	Rheumatoid Arthritis 08/2015 - 07/2013
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2013 - 08/2012
1	Localized Scleroderma (Morphea) 01/2022
1	Atherosclerosis 01/2017
1	Infections 04/2016
1	Wounds and Injuries (Trauma) 04/2016
1	Alopecia Areata 01/2016
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2015
1	Allergic Contact Dermatitis 03/2015
1	Contact Dermatitis (Eczema, Contact) 03/2015
1	Vasculitis (Vasculitides) 07/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2013
1	Proteinuria 07/2013
1	Systemic Scleroderma (Systemic Sclerosis) 07/2013
1	Ankylosing Spondylitis 07/2013
1	Connective Tissue Diseases (Connective Tissue Disease) 07/2013
1	Renal Insufficiency (Renal Failure) 11/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Neoplasms (Cancer) 01/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Chest Pain (Chest Pains) 01/2011
1	Cough 01/2011
1	Edema (Dropsy) 01/2011
1	Takotsubo Cardiomyopathy 01/2011
1	Latent Tuberculosis 01/2011
1	Arthralgia (Joint Pain) 01/2011
1	Pneumonia (Pneumonitis) 01/2011
1	Pleural Effusion (Pleural Effusions) 01/2011
1	Dyspnea (Shortness of Breath) 01/2011
1	Peripheral Arterial Disease 05/2009
1	Rupture 08/2008

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2019 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2017
2	Interleukin-22 (IL-22)IBA 01/2019 - 01/2018
2	fezakinumabIBA 01/2019 - 01/2018
2	Interleukin-12 (IL 12)IBA 01/2017 - 01/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2014 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 08/2008
1	apremilastIBA 01/2022
1	dupilumabIBA 05/2021
1	ixekizumabIBA 05/2018
1	Monoclonal AntibodiesIBA 01/2018
1	CD40 Ligand (CD40L)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2017
1	Chemokine CX3CL1IBA 01/2017
1	Petrolatum (Vaseline)FDA Link 04/2016
1	SteroidsIBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2015
1	Biological ProductsIBA 08/2015
1	Rituximab (Mabthera)FDA Link 08/2015
1	AllergensIBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2014
1	Interleukin-13IBA 06/2014
1	ElafinIBA 06/2014
1	anti-thyroglobulinIBA 07/2013
1	Iodide Peroxidase (Deiodinase)IBA 07/2013
1	AntibodiesIBA 07/2013
1	Prednisone (Sone)FDA LinkGeneric 11/2011
1	Hormones (Hormone)IBA 01/2011
1	Coloring Agents (Dyes)IBA 01/2011
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2011
1	Opioid Analgesics (Opioids)IBA 01/2011
1	Methadone (Dolophine)FDA LinkGeneric 01/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2011

Therapy/Procedure

6	Therapeutics 04/2016 - 08/2008
1	Ambulatory Surgical Procedures (Outpatient Surgery) 04/2016
1	Resistance Training 05/2009